Skip to main content
. 2017 Sep 14;7:11621. doi: 10.1038/s41598-017-12022-1

Table 3.

ROC analysis of serum biomarkers individually and combined for GC detection

Models AUC(95%CI) P -value
Single-model PGI 0.549(0.506–0.595)
PGII 0.641(0.596–0.682)
PGI/II 0.735(0.696–0.773)
HpAb 0.736(0.700–0.775)
OPN 0.715(0.675–0.752)
Dual-model PGI/II-OPN 0.787(0.752–0.822) <0.001a, <0.001b
PGI/II-HpAb 0.786(0.751–0.820) <0.001a, <0.001c
OPN- HpAb 0.801(0.768–0.834) <0.001b, <0.001c
Tri-model PGI/II-HpAb-OPN 0.826(0.795–0.858) <0.001d, <0.001e,0.006f
Lauren classification
intestinal 0.827(0.796–0.858) 0.219g
diffuse 0.826(0.795–0.858)
Tumor stage
early 0.821(0.789–0.852) 0.469h
late 0.816(0.784–0.848)

aCompared with the AUC of PGI/II.

bCompared with the AUC of OPN.

cCompared with the AUC of HpAb.

dCompared with the AUC of PGI/II-OPN.

eCompared with the AUC of PGI/II-HpAb.

fCompared with the AUC of OPN- HpAb.

gCompared with the AUC between Lauren classification.

hCompared with the AUC between stage.